Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"excerpt":{"rendered":"
Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"ism_preview":{"drugs":[{"title":"Maraviroc","url":"https:\/\/www.ortaakarsu.net\/?ism_drug=maraviroc","facts":[{"label":"Active ingredient \/ generic name","value":"maraviroc"},{"label":"ATC code","value":"J05AX09"},{"label":"Administration route","value":"Oral"}]},{"title":"Rifcap 300 mg Kaps\u00fcl (Turkish record)","url":"https:\/\/www.ortaakarsu.net\/?ism_drug=rifcap-300-mg-kapsul","facts":[{"label":"Active ingredient \/ generic name","value":"Rifampisin"},{"label":"ATC code","value":"J04AB02"}]}],"record":[{"label":"Record type","value":"Published interaction record"},{"label":"Source record version","value":"SPL v26; effective 2022-09-26; posted 2026-06-24; checked 2026-11-04"}],"sources":[{"label":"DailyMed: Selzentry (maraviroc), ViiV prescribing information","url":"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=46f30ac5-c96b-429e-976d-8c5ee1c0761b"},{"label":"FDA: Examples of drugs that interact with CYP enzymes and transporters","url":"https:\/\/www.fda.gov\/drugs\/drug-interactions-labeling\/healthcare-professionals-fdas-examples-drugs-interact-cyp-enzymes-and-transporter-systems"}],"reviewed_at":"2026-11-04"},"ism_access":{"required":true,"resource_key":"pair:35972","available":true}}